PMC:7377212 / 652-841 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T14","span":{"begin":49,"end":57},"obj":"SP_7"},{"id":"T15","span":{"begin":67,"end":80},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T16","span":{"begin":115,"end":121},"obj":"NCBITaxon:4751"},{"id":"T17","span":{"begin":150,"end":158},"obj":"SP_7"},{"id":"T18","span":{"begin":170,"end":179},"obj":"UBERON:0002048"},{"id":"T59221","span":{"begin":49,"end":57},"obj":"SP_7"},{"id":"T9877","span":{"begin":67,"end":80},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T12804","span":{"begin":115,"end":121},"obj":"NCBITaxon:4751"},{"id":"T73228","span":{"begin":150,"end":158},"obj":"SP_7"},{"id":"T60783","span":{"begin":170,"end":179},"obj":"UBERON:0002048"}],"text":" a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergill"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"T16","span":{"begin":125,"end":134},"obj":"Disease"},{"id":"T17","span":{"begin":150,"end":158},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergill"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":1,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergill"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":67,"end":80},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":" a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergill"}